Skip to Content

ER 414 (Pramipexole Dihydrochloride Extended-Release 3.75 mg)

Pill with imprint ER 414 is White, Elliptical / Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 3.75 mg. It is supplied by Alembic Pharmaceuticals Inc..

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 3.75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ER 414

Pramipexole Dihydrochloride Extended-Release

ER 414
3.75 mg
Elliptical / Oval
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alembic Pharmaceuticals Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.